NRXP — NRX Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $107.81m
- $81.53m
- $1.23m
Brief: Nrx Pharmaceuticals Announces Signing Of A Data And Technical Information Agreement With Columbia University
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower
U.S. STOCKS ON THE MOVE-Occidental Petroleum, Scorpio Tankers, ZimVie
U.S. STOCKS ON THE MOVE-Micron, PGT Innovations, Adobe
NRX Pharma gains as FDA allows human trials for UTI drug
Brief: NRx Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for NRX-101
U.S. STOCKS ON THE MOVE-Paramount Global, Bumble, Booking Holdings
U.S. STOCKS ON THE MOVE-Constellation Energy, Bloomin' Brands, Air Lease
U.S. STOCKS ON THE MOVE-Sensei, Celldex, Bluegreen Vacations
NRx Pharma rises on contract to develop suicidal depression treatment
Brief: NRX Pharmaceuticals And Nephron Pharmaceuticals Agree To Develop Intravenous Ketamine To Treat Suicidal Depression
Brief: NRx Pharmaceuticals Announces Further Alignment with FDA on Initiation of Registrational Trials for NRX-101
Brief: NRX Pharmaceuticals Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq On Oct 17
Brief: NRX Pharmaceuticals Announces Strategic Change In Development Of Nrx-100 (IV Ketamine)
U.S. STOCKS ON THE MOVE-Amazon.com, US airlines, SolarEdge, Dynatronics
U.S. STOCKS ON THE MOVE-Invitae Corp, Aemetis, Discover Financial Services, Nvidia
U.S. STOCKS ON THE MOVE-Guardforce AI, Sphere Entertainment, Acurx Pharma
U.S. STOCKS ON THE MOVE-Datadog, Rivian, crypto stocks
NRx Pharma rises as pain treatment drug human trials gets FDA approval